It was almost three years ago that we had the pleasure of welcoming Dr. Abdourahmane Diallo as the CEO for the Partnership. He brought deep experience and insights to the role which he honed as the Minister and Health Advisor to the President of Guinea and as Minister of Health of Guinea. During his time as CEO of the Partnership he has been a steady, trusted, and vocal advocate for the reduction of malaria burden across the African continent and the world, towards the goal of eradication within a generation. After almost three years of leading the Partnership as CEO, Dr. Diallo has decided to leave the Partnership, for personal reasons, at the end of March 2022.
He leaves the Partnership well-positioned to fulfill its mission: an ambitious strategy was approved in 2020 to take the Partnership through 2025, the staffing model of the Secretariat has been revised to better meet the needs of implementing the strategy, and the financial position of the Secretariat has been clarified and strengthened during the course of 2021.
The Board is committed to appointing an interim CEO by April 2022 to ensure continuity in the critical work of the Partnership; in addition, the Board recommits to the principles of diversity, equity, and inclusion and will prioritize selecting an interim CEO and a permanent CEO from an implementing country. We acknowledge that this is a critical year for the global malaria community. The entire RBM Partnership Board, the Partnership Committees, the Secretariat and the broader Partnership are fully committed to the long-term success of the RBM Partnership. We would like to take this opportunity to express our deep appreciation to Dr. Diallo and the entire Secretariat for their commitment and hard work, as well as for their resilience during the past two years of the pandemic.
Professor Maha Barakat